[go: up one dir, main page]

DE69738406D1 - Verbesserungen in oder an Kontrastmitteln - Google Patents

Verbesserungen in oder an Kontrastmitteln

Info

Publication number
DE69738406D1
DE69738406D1 DE69738406T DE69738406T DE69738406D1 DE 69738406 D1 DE69738406 D1 DE 69738406D1 DE 69738406 T DE69738406 T DE 69738406T DE 69738406 T DE69738406 T DE 69738406T DE 69738406 D1 DE69738406 D1 DE 69738406D1
Authority
DE
Germany
Prior art keywords
contrast agents
agents
contrast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69738406T
Other languages
English (en)
Other versions
DE69738406T2 (de
Inventor
Jonny Ostensen
Sigmund Frigstad
Morten Eriksen
Pal Rongved
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
GE Healthcare AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9621884.7A external-priority patent/GB9621884D0/en
Priority claimed from GBGB9708239.0A external-priority patent/GB9708239D0/en
Application filed by GE Healthcare AS filed Critical GE Healthcare AS
Application granted granted Critical
Publication of DE69738406D1 publication Critical patent/DE69738406D1/de
Publication of DE69738406T2 publication Critical patent/DE69738406T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/928—X-ray agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/929—Ultrasound contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69738406T 1996-10-21 1997-10-21 Verbesserungen in oder an Kontrastmitteln Expired - Lifetime DE69738406T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9621884.7A GB9621884D0 (en) 1996-10-21 1996-10-21 Improvements in or relating to contrast agents
GB9621884 1996-10-21
GB9708239 1997-04-23
GBGB9708239.0A GB9708239D0 (en) 1997-04-23 1997-04-23 Improvements in or relating to contrast agents

Publications (2)

Publication Number Publication Date
DE69738406D1 true DE69738406D1 (de) 2008-01-31
DE69738406T2 DE69738406T2 (de) 2008-12-04

Family

ID=26310262

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69721331T Expired - Lifetime DE69721331T2 (de) 1996-10-21 1997-10-21 Verbesserungen für oder in bezug auf kontrastmitteln in ultraschallbilddarstellung
DE69738406T Expired - Lifetime DE69738406T2 (de) 1996-10-21 1997-10-21 Verbesserungen in oder an Kontrastmitteln

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69721331T Expired - Lifetime DE69721331T2 (de) 1996-10-21 1997-10-21 Verbesserungen für oder in bezug auf kontrastmitteln in ultraschallbilddarstellung

Country Status (26)

Country Link
US (3) US6375931B2 (de)
EP (2) EP1007100B1 (de)
JP (1) JP2001502349A (de)
KR (1) KR20000052652A (de)
CN (1) CN1106859C (de)
AP (1) AP885A (de)
AT (2) ATE381353T1 (de)
AU (1) AU745047B2 (de)
BG (1) BG103402A (de)
BR (1) BR9712370A (de)
CA (1) CA2269319C (de)
CZ (1) CZ140999A3 (de)
DE (2) DE69721331T2 (de)
EE (1) EE03749B1 (de)
ES (1) ES2197336T3 (de)
HU (1) HU224218B1 (de)
ID (1) ID21681A (de)
IL (1) IL129423A (de)
MX (1) MXPA99003664A (de)
NO (1) NO991869L (de)
NZ (1) NZ335265A (de)
PL (1) PL332820A1 (de)
RU (1) RU2204415C2 (de)
SK (1) SK283210B6 (de)
TR (1) TR199901544T2 (de)
WO (1) WO1998017324A2 (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
DE69724599T2 (de) * 1996-03-12 2004-08-05 The Board Of Regents Of The University Of Nebraska, Lincoln Zusammensetzung zur zielortspezifischen verabreichung eines medikamentes und verfahren zur anwendung
CA2263568C (en) * 1996-09-11 2008-12-02 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a contrast agent and a renal vasodilator
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
TR199901544T2 (xx) * 1996-10-21 1999-09-21 Nycomed Imaging As Kontrast ajanlar�ndaki veya kontrast ajanlar�yla ilgili geli�meler.
GB9708246D0 (en) * 1997-04-24 1997-06-18 Nycomed Imaging As Improvements in or relating to ultrasound imaging
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
GB9717588D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
WO1999020312A1 (en) * 1997-10-21 1999-04-29 Nycomed Imaging As Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19805012A1 (de) * 1998-02-07 1999-08-12 Thomas Gieselmann Kontrastmittel zur Verwendung als Diagnostikum bei bildgebenden Verfahren sowie seine Herstellung
GB9808581D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
GB9808582D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
US20040170564A1 (en) * 1998-04-22 2004-09-02 Roald Skurtveit Ultrasound contrast agent dispersions comprising gas and destabilising agent
GB9808599D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or realting to contrast agents
GB9813568D0 (en) * 1998-06-23 1998-08-19 Nycomed Imaging As Improvements in or relating to cardiac imaging
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
NO20010234D0 (no) * 2001-01-12 2001-01-12 Nycomed Imaging As Perfusjon avbildningsbilde
US7179449B2 (en) * 2001-01-30 2007-02-20 Barnes-Jewish Hospital Enhanced ultrasound detection with temperature-dependent contrast agents
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
US20080193490A1 (en) * 2002-02-14 2008-08-14 Andreas Hirsch Use of Carbon Nanotube for Drug Delivery
US20040166152A1 (en) * 2002-02-14 2004-08-26 Andreas Hirsch Use of buckysome or carbon nanotube for drug delivery
EP1587944A4 (de) 2002-03-01 2007-03-21 Dyax Corp Kdr und vegf/kdr-bindende peptide und ihre diagnostische und therapeutische veranwendung bei der diagnose und therapie
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
CA2477836A1 (en) 2002-03-01 2003-09-12 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US20090060992A1 (en) * 2002-05-08 2009-03-05 University Of Central Florida Research Foundation, Inc., Preparation of magneto-vesicles with DOPE/DDAB layers
US7623903B2 (en) * 2002-05-17 2009-11-24 Wacker Frank K Double contrast technique for MRI-guided vascular interventions
US7767232B2 (en) * 2002-09-19 2010-08-03 New York University Control of nitric oxide bioactivity by perfluorocarbons
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
WO2004068405A2 (en) * 2003-01-25 2004-08-12 Oraevsky Alexander A High contrast optoacoustical imaging using nanoparticles
US20040146461A1 (en) * 2003-01-29 2004-07-29 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
US7378081B2 (en) 2003-01-29 2008-05-27 Vincon Research Enterprises, Llc Composition and method for direct visualization of the human appendix
ATE371460T1 (de) * 2003-01-31 2007-09-15 Otsuka Pharma Co Ltd Hilfsstoff zum einsatz bei der krebstherapie mittels dielektrischer erwärmung und krebstherapieverfahren
JP4670083B2 (ja) * 2003-02-04 2011-04-13 ブラッコ・シュイス・ソシエテ・アノニム 超音波造影剤およびその製造方法
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
US20050214859A1 (en) 2003-03-03 2005-09-29 Dyax Corp. Peptides that specifically bind HGF receptor (cMet) and uses thereof
US20040258760A1 (en) * 2003-03-20 2004-12-23 Wheatley Margaret A. Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
US20080299047A1 (en) * 2003-07-31 2008-12-04 National Cheng Kung University Method for preparation of water-soluble and dispersed iron oxide nanoparticles and application thereof
SE526838C2 (sv) * 2003-11-27 2005-11-08 Xcounter Ab Undersökningsmetod och anordning för detektion av joniserande strålning
EP1701745B1 (de) * 2003-12-22 2014-12-10 Bracco Suisse S.A. Gasgefüllte mikrovesikel-anordnung für die kontrastdarstellung
RU2346693C2 (ru) * 2004-01-27 2009-02-20 Си Ви Терапьютикс, Инк. Визуализация перфузии миокарда с использованием агонистов аденозиновых рецепторов
AU2005232441B2 (en) * 2004-04-13 2010-11-11 Cambridge Biostability Limited Liquids containing suspended glass particles
US8012457B2 (en) * 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
WO2006018433A1 (en) 2004-08-18 2006-02-23 Bracco Research Sa Gas-filled microvesicles composition for contrast imaging
US8034222B2 (en) * 2004-10-26 2011-10-11 The Regents Of The University Of California Conducting polymer nanowire sensors
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
US20070167864A1 (en) * 2005-11-29 2007-07-19 Lopez George A Cardiac output measurement devices and methods
JP5242408B2 (ja) 2005-12-09 2013-07-24 ブラッコ・スイス・ソシエテ・アノニム ターゲットベクター・リン脂質コンジュゲート
US7494603B2 (en) * 2006-02-28 2009-02-24 E. I. Du Pont De Nemours And Company Azeotropic compositions comprising fluorinated compounds for cleaning applications
CN100400105C (zh) * 2006-05-11 2008-07-09 上海交通大学 水性基质的消化道ct阴性造影剂及其制备方法
JP4279328B2 (ja) * 2007-05-07 2009-06-17 株式会社日立製作所 超音波撮像システム
RU2387365C2 (ru) * 2007-08-15 2010-04-27 Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО НижГМА Росздрава) Способ исследования состояния кожи методом оптической когерентной томографии
KR100957560B1 (ko) * 2007-10-18 2010-05-11 한국생명공학연구원 양자점 나노입자를 함유한 퍼플루오르카본 나노에멀젼 및그 제조방법
RU2367443C1 (ru) * 2008-02-28 2009-09-20 Общество с ограниченной ответственностью "Битеп" Средство на основе природных фосфолипидов
GB0811856D0 (en) * 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
US8908939B2 (en) * 2008-09-30 2014-12-09 Koninklijke Philips N.V. Perfusion imaging
US9072490B2 (en) * 2010-12-20 2015-07-07 Toshiba Medical Systems Corporation Image processing apparatus and image processing method
ITRM20110022A1 (it) * 2011-01-21 2012-07-22 Gaio Paradossi Metodo per la preparazione di microbolle comprendenti un agente di contrasto
RU2454174C2 (ru) * 2011-03-16 2012-06-27 Федеральное государственное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена" Министерства здравоохранения и социального развития Российской Федерации (ФГУ "МНИОИ им. П.А. Герцена" Минздравсоцразвития России) Способ диагностики опухолей шейки матки
RU2453270C1 (ru) * 2011-03-31 2012-06-20 Федеральное государственное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена Министерства здравоохранения и социального развития Российской Федерации" (ФГУ "МНИОИ им. П.А. Герцена" Минздравсоцразвития России) Способ исследования терминального отдела толстой кишки
RU2485976C2 (ru) * 2011-05-17 2013-06-27 Государственное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГОУ ВПО СибГМУ Минздравсоцразвития России) Контрастное средство для ультразвуковой визуализации
MX374926B (es) * 2012-04-30 2025-03-06 Ge Healthcare As Metodo para llenar un contenedor con una composicion espumable.
RU2640078C2 (ru) * 2012-06-26 2017-12-26 ДжиИ Хелткер АС Получение композиции, содержащей микропузырьки газа
CN103100093B (zh) * 2013-01-23 2015-05-06 中山大学附属第三医院 一种负载小干扰rna的纳米级脂质微泡超声造影剂及制备方法
DK3049117T3 (da) 2013-09-27 2022-10-31 Exact Therapeutics As Ultralydsmedieret afgivelse af lægemidler
CA2972423A1 (en) 2014-12-31 2016-07-07 Lantheus Medical Imaging, Inc. Lipid-encapsulated gas microsphere compositions and related methods
EP3452108A4 (de) 2016-05-04 2019-12-25 Lantheus Medical Imaging, Inc. Verfahren und vorrichtungen zur herstellung von ultraschallkontrastmitteln
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof
US11642172B2 (en) * 2019-03-05 2023-05-09 Biosense Webster (Israel) Ltd. Showing catheter in brain
US12005130B2 (en) 2019-10-16 2024-06-11 Agitated Solutions Inc. Generating microbubbles for bubble studies
US11191888B1 (en) 2020-05-18 2021-12-07 Agitated Solutions Inc. Syringe-based microbubble generator
RU2744825C1 (ru) * 2020-06-03 2021-03-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Смоленский государственный медицинский университет" министерства здравоохранения Российской Федерации Способ определения времени течения артериальной фазы эхоконтрастирования печени, почек и селезенки
US20220079499A1 (en) * 2020-09-14 2022-03-17 Biosense Webster (Israel) Ltd. Identification of ablation gaps

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5117830A (en) * 1990-11-08 1992-06-02 Whitby Research, Inc. Method of determining viability of tissue
DE69427185T2 (de) * 1993-01-25 2001-12-06 Sonus Pharmaceutical, Inc. Phase-Stift Kolloide zur Verwendung als Ultraschallkontrastmittel
US5362478A (en) * 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
DE69434119T3 (de) * 1993-07-30 2011-05-05 Imcor Pharmaceutical Co., San Diego Stabilisierte mikrogasbläschen-zusammensetzungen für echographie
US5798091A (en) * 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
DE4406474A1 (de) * 1994-02-23 1995-08-24 Schering Ag Gas enthaltende Mikropartikel, diese enthaltende Mittel, deren Verwendung in der Ultraschalldiagnostik, sowie Verfahren zur Herstellung der Partikel und Mittel
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5560364A (en) * 1995-05-12 1996-10-01 The Board Of Regents Of The University Of Nebraska Suspended ultra-sound induced microbubble cavitation imaging
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
TR199901544T2 (xx) * 1996-10-21 1999-09-21 Nycomed Imaging As Kontrast ajanlar�ndaki veya kontrast ajanlar�yla ilgili geli�meler.
US6054118A (en) * 1997-01-22 2000-04-25 Nycomed Imaging As Contrast agents comprising two types of gas-containing microparticles

Also Published As

Publication number Publication date
AU745047B2 (en) 2002-03-07
DE69721331D1 (de) 2003-05-28
JP2001502349A (ja) 2001-02-20
US20050118104A1 (en) 2005-06-02
US6783752B2 (en) 2004-08-31
EP1007100B1 (de) 2003-04-23
WO1998017324A3 (en) 1998-06-25
BG103402A (bg) 2000-01-31
EE9900158A (et) 1999-12-15
SK52099A3 (en) 2000-01-18
ES2197336T3 (es) 2004-01-01
SK283210B6 (sk) 2003-03-04
EP1264604A2 (de) 2002-12-11
EP1007100A2 (de) 2000-06-14
US20010002993A1 (en) 2001-06-07
CA2269319A1 (en) 1998-04-30
RU2204415C2 (ru) 2003-05-20
EE03749B1 (et) 2002-06-17
CZ140999A3 (cs) 1999-09-15
IL129423A (en) 2003-01-12
DE69738406T2 (de) 2008-12-04
ATE381353T1 (de) 2008-01-15
AP885A (en) 2000-11-03
CA2269319C (en) 2008-03-18
WO1998017324A2 (en) 1998-04-30
NO991869D0 (no) 1999-04-19
ID21681A (id) 1999-07-08
EP1264604A3 (de) 2004-03-10
KR20000052652A (ko) 2000-08-25
HUP0000282A2 (hu) 2000-05-28
DE69721331T2 (de) 2004-05-06
HU224218B1 (hu) 2005-06-28
TR199901544T2 (xx) 1999-09-21
CN1106859C (zh) 2003-04-30
PL332820A1 (en) 1999-10-11
AU4714797A (en) 1998-05-15
HUP0000282A3 (en) 2001-09-28
MXPA99003664A (es) 2002-06-11
NO991869L (no) 1999-06-02
BR9712370A (pt) 1999-08-31
CN1238699A (zh) 1999-12-15
NZ335265A (en) 2000-07-28
IL129423A0 (en) 2000-02-17
US6375931B2 (en) 2002-04-23
EP1264604B1 (de) 2007-12-19
US20040141921A1 (en) 2004-07-22
ATE238073T1 (de) 2003-05-15
AP9901511A0 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
DE69738406D1 (de) Verbesserungen in oder an Kontrastmitteln
BR9711781A (pt) Mancal
DE59708196D1 (de) Rastschaltwerk
DE69720774D1 (de) S-omeprazol in festform
DE59700704D1 (de) Gleitlager
NO985294D0 (no) Kontrastmidler
FI960090A0 (fi) Naetadapter samt dataoeverfoeringsfoerfarande i mobiltelenaet
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
DE69511918D1 (de) Kugellager
PT811593E (pt) Agentes insecticidas e acaricidas 1,4-diaril-2-fluor-2-buteno
DE69500685D1 (de) Verbesserungen an/oder bezüglich Elektromagneten
BR9500450A (pt) Mancal elástico
DE69724751D1 (de) Verbesserungen an oder bezüglich elektronischen Systemen
DE69709700D1 (de) Kontrastmittel
DE69700488D1 (de) Verbesserungen in oder bezüglich Telekommunikationssystemen
DE59400686D1 (de) Gummilager
KR970011854U (ko) 속치마가 일체로 된 한복
DE19780531D2 (de) Spannstock
ES1033079Y (es) Sujecion de objetos en estuches.
KR970061098U (ko) 분도기겸용 접철자
FI1691U1 (fi) Hopsaettningsmaskin foer lastpallsben
FI960919A0 (fi) Bandlaos foer balettskor
DE69735006D1 (de) Kontrastmittel
ATE249247T1 (de) Kontrastmittel
IT240081Y1 (it) Cuscinetto

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB